Lyra Therapeutics: Advancing An Innovative Solution For Chronic Rhinosinusitis Seeking Alpha, 09 Jul 2020 Lyra Therapeutics (NASDAQ: LYRA ) is seeking to advance a new treatment modality for a very common condition called chronic…